2 Profitable U.S.-Focused Cannabis Companies You Should Consider Buying

Curaleaf Holdings (CNSX:CURA) and Charlotte’s Web Holdings Ltd (CNSX:CWEB) are making serious strides in the U.S. cannabis market. Which is the better buy?

The marijuana industry in Canada is currently evolving at a fast pace. Sales have gone through the roof since recreational use of pot was legalized last year. However, many marijuana companies are choosing to do business south of the border; after all, the U.S. is the largest market in the world. Let’s look at two U.S.-focused pot companies investors should keep an eye on: Curaleaf Holdings (CNSX:CURA) and Charlotte’s Web Holdings (CSNX:CWEB). Which is the better buy?

The case for Curaleaf Holdings

Investors not yet familiar with Curaleaf should catch up; the Vancouver-based firm recently announced the largest U.S.-focused acquisition in the marijuana industry to date.

This is quite the accomplishment, especially considering there have been many such acquisitions in recent months, each bigger than the last. Curaleaf agreed to acquire Cura Partners — a Portland-based cannabis oil producer — for an all-stock deal worth $1.27 billion. Curaleaf will relinquish about 16% ownership to Cura Partners.

This deal will bolster Curaleaf’s already strong operations. The firm boasts 44 dispensaries, 12 cultivation sites, and 11 sites across 12 U.S. states. Note that since the interstate transport of marijuana is illegal (due to it being classified as a controlled one substance), Curaleaf is forced to grow and sell cannabis within the bounds of a particular state. Curaleaf’s operations were concentrated in the east, but that is set to change with the Cura Partners acquisition.

Curaleaf’s revenues are very respectable by industry’s standard. For Q4 2018, the company reported revenues of US$31,961 (about $42,968). Among the biggest Canadian pot companies, only Canopy Growth and Aurora Cannabis reported higher earnings.

Curaleaf also posted a gross profit margin of 50%. Though the firm isn’t yet profitable, its recent acquisition should help its sales and revenues skyrocket further. The future looks bright for Curaleaf.

The case for Charlotte’s Web Holdings

Few companies benefited from the passage of the Farm Bill as much as Charlotte’s Web did. The piece of legislation that made hemp legal in the states led to a significant rise in the number of retail location the firm owns and operates.

The Colorado-based firm now owns over 6,000 retail locations across the U.S, which is more than 60% the number it had at the end of 2018. Charlotte’s Web’s production capacity is likely to follow a similar progression. Last year, the firm planted 300 acres of hemp — a more than 400% increase from 2017. Charlotte’s Web is set to at least double that number this year.

Charlotte’s Web boasts excellent financial results. During the fourth quarter of 2018, the company reported revenues of US$21.45 million and a net income of US$3.15 million (or about $28.83 million and $4.23 million, respectively).

The marijuana company has been consistently profitable for a while now, though its earnings are a bit volatile. Charlotte’s Web’s share price soared during the first quarter of the year but has slowed down since. 

The verdict

Both cannabis stocks have their strengths and their weaknesses. Curaleaf beats Charlotte’s Web in terms of sales and revenues and is on the verge of significantly improving its prospects thanks to its acquisition of Cura Partners. However, it isn’t consistently profitable yet, and still has to contend with pot being illegal at the federal level.

Charlotte’s Web operates within the CBD hemp market, which is now a legal substance. The firm’s production capacity and sales have been soaring, and it is already profitable. Though Charlotte’s Web looks like the better buy right now, Curaleaf might have the better long-term upside.

Should you invest $1,000 in Enbridge right now?

Before you buy stock in Enbridge, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Enbridge wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny owns shares of Aurora Cannabis.  

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »